Beck Bode, LLC United Therapeutics Corp Transaction History

Beck Bode, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$228.26 - $319.04 $18,032 - $25,204	79 Added 0.99%	8,084 $2.58 Million
Q1 2024 May 22, 2024	BUY	$210.76 - $249.51 $1.69 Million - $2 Million	8,005 New	8,005 $1.84 Million
Q4 2021 Feb 07, 2022	SELL	$184.32 - $216.08 $5.21 Million - $6.11 Million	-28,286 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$179.86 - $214.88 $5.09 Million - $6.08 Million	28,286 New	28,286 $5.22 Million

671

42.3M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Beck Bode, LLC, based on Form 13F filings with the SEC.

Stay updated on Beck Bode, LLC with notifications on news.